Clinical trial

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With…

NCT00197808 · Public Health England, Other · Completed

Key facts

NCT number NCT00197808
Title Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
Official title Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
Acronym sched1
Lead sponsor Public Health England, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Pneumococcal Infections, Meningococcal Infections
Intervention type Biological
Interventions menjugate, Men C conjugate vaccine, Men C conjugate, Men C Conjugate
Enrollment 392
Start date Apr 1, 2005
Primary completion Jan 1, 2010
Completion Jan 1, 2010
First posted Sep 20, 2005
Last update posted Oct 1, 2020
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies